- Home
- Calendar of Events
- Webinars
Featured Events
-
Cancer Data Champions
Webinar
All Months
-
Essential Steps for Navigating the Accreditation Journey
Nov 26, 2024 8:00 AM - 9:00 PM CT -
Connecting the Multidisciplinary Care Team
Dec 3, 2024 7:00 PM - 8:00 PM CTIt's not always easy to deliver the message of your diagnosis concisely and clearly to your treating physician colleagues. Hear from experienced speakers who will share insights on how to reduce questions regarding laboratory testing and ensure that treating physicians are able to properly interpret your reports.
-
Level Up Your Pathology Interest Group
Dec 5, 2024 7:00 PM - 8:00 PM CTJoin our panel of medical students and pathology residents for an engaging discussion and shared insights on pathology interest groups (PIG) and how to start one at your institution.
-
Staying in Sync: CAP Accreditation Checklist Changes for 2024
Dec 18, 2024 12:00 PM - 1:15 PM CTThis Focus on Compliance webinar will explore the key changes, rationale, and opportunities of the 2024 CAP Accreditation Program changes.
-
Ready Your Laboratory for the FDA’s Stage 1: Corrective Action and Removal Reporting
Jan 9, 2025 12:00 PM - 1:00 PM CTPart three of a six-part webinar series on understanding and preparing for the impact of the FDA’s LDT final rule.
-
Personnel Essentials: A Deep Dive into Personnel Roles and Qualifications
Feb 19, 2025 12:00 PM - 1:00 PM CT -
Ready Your Laboratory for the FDA’s Stage 1: Rules for Quality System Complaint Processes
Mar 20, 2025 12:00 PM - 1:00 PM CTPart four of a six-part series on understanding and preparing for the impact of the FDA’s LDT final rule.
-
How Enforcement Discretion Categories & Modification Rules Apply to Your LDTs
May 8, 2025 12:00 PM - 1:00 PM CTPart five of a six-part webinar series on understanding and preparing for the impact of the FDA’s LDT final rule.
-
Navigating the FDA’s LDT Oversight Requirements During a Public Health Emergency
Jul 10, 2025 12:00 PM - 1:00 PM CTPart six of a six-part webinar series on understanding and preparing for the impact of the FDA’s LDT final rule.